Quest Diagnostics Inc. Stock
Quest Diagnostics Inc. Stock
Heavy losses for Quest Diagnostics Inc. today as the stock fell by -€5.200 (-3.080%).
Currently there is a rather positive sentiment for Quest Diagnostics Inc. with 5 Buy predictions and 0 Sell predictions.
With a target price of 170 € there is a slightly positive potential of 4.07% for Quest Diagnostics Inc. compared to the current price of 163.35 €.
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | -3.080% | -4.334% | -5.578% | 13.045% | 9.521% | 23.938% | 53.452% |
| Anthem Inc. | -0.180% | 1.879% | 6.110% | -31.468% | -9.749% | -40.956% | -12.368% |
| HCA Holdings Inc. | -1.820% | 3.300% | -8.903% | 43.839% | 4.916% | 69.855% | 169.086% |
| Universal Health Services B | 0.000% | 0.649% | -3.727% | 0.000% | -19.271% | 27.049% | 33.563% |
Comments
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat